| Issue Date |
Title |
Author(s) |
| 1-Jun-2023 |
ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3-targeting antibody-drug conjugate, in patients with advanced solid tumor |
Wang, Jie;Duan, Jianchun;Xing, Ligang;Sun, Yuping;Guo, Wei;Wang, Haiying;Chen, Jianhua;Han, Liang;Liu, Baogang;Wang, Qiming;Hu, Ying;Wei, Hongying;Li, Chuan;Huang, Qiqi;Dong, Yiwei;Wu, Qiong |
| 2019 |
Design and understanding of core/branch-structured VS2 nanosheets@CNTs as high-performance anode materials for lithium-ion batteries |
Li, Xing;Fu, Jiatian;Sun, Yuping;Sun, Mei;Cheng, Shaobo;Chen, Kaijian;Yang, Xigui;Lou, Qing;Xu, Tingting;Shang, Yuanyuan;Xu, Junmin;Chen, Qing;Shan, Chongxin |
| Oct-2021 |
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study |
Peng, Zhi;Liu, Tianshu;Wei, Jia;Wang, Airong;He, Yifu;Yang, Liuzhong;Zhang, Xizhi;Fan, Nanfeng;Luo, Suxia;Li, Zhen;Gu, Kangsheng;Lu, Jianwei;Xu, Jianming;Fan, Qingxia;Xu, Ruihua;Zhang, Liangming;Li, Enxiao;Sun, Yuping;Yu, Guohua;Bai, Chunmei;Liu, Yong;Zeng, Jiangzheng;Ying, Jieer;Liang, Xinjun;Xu, Nong;Gao, Chao;Shu, Yongqian;Ma, Dong;Dai, Guanghai;Li, Shengmian;Deng, Ting;Cui, Yuehong;Fang, Jianmin;Ba, Yi;Shen, Lin |
| Aug-2022 |
Efficacy and safety of selpercatinib in Chinese patients with advanced RET-altered thyroid cancers: results from the phase II LIBRETTO-321 study |
Zheng, Xiangqian;Ji, Qinghai;Sun, Yuping;Ge, Minghua;Zhang, Bin;Cheng, Ying;Lei, Shangtong;Shi, Feng;Guo, Ye;Li, Linfa;Chen, Lu;Shao, Jingxin;Zhang, Wanli;Gao, Ming |
| 2019 |
Flexible and multi-form solid-state supercapacitors based on polyaniline/graphene oxide/CNT composite films and fibers |
Jiang, Qiaoya;Shang, Yuanyuan;Sun, Yuping;Yang, Yawei;Hou, Siyu;Zhang, Yingjiu;Xu, Jie;Cao, Anyuan |
| Jan-2022 |
Geological and Engineering Integrated Shale Gas Sweet Spots Evaluation Based on Fuzzy Comprehensive Evaluation Method: A Case Study of Z Shale Gas Field HB Block |
Liu, Shiqi;Liu, Yuyang;Zhang, Xiaowei;Guo, Wei;Kang, Lixia;Yu, Rongze;Sun, Yuping |
| 2019 |
High efficiency CNT-Si heterojunction solar cells by dry gas doping |
Zhao, Xuewei;Wu, Huaisheng;Yang, Liusi;Wu, Yizeng;Sun, Yuping;Shang, Yuanyuan;Cao, Anyuan |
| 12-Apr-2021 |
High performance carbon nanotube/polymer composite fibers and water-driven actuators |
Sun, Yuping;Hou, Keheng;Zhang, Ding;Chang, Shulong;Ye, Li;Cao, Anyuan;Shang, Yuanyuan |
| 2019 |
Highly Stretchable Carbon Nanotube Fibers with Tunable and Stable Light Emission |
Sun, Yuping;Li, Shuhui;Shang, Yuanyuan;Hou, Siyu;Chang, Shulong;Shi, Enzheng;Cao, Anyuan |
| 18-Dec-2020 |
Immune-Related Neurological Toxicities of PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis |
Tian, Yuan;Gao, Aiqin;Wen, Qing;Wang, Shuyun;Zhang, Shuisheng;Yang, Xiaowei;Su, Guohai;Sun, Yuping |
| 2019 |
Improving Carbon Nanotube-Silicon Solar Cells by Solution Processable Metal Chlorides |
Wu, Huaisheng;Zhao, Xuewei;Sun, Yuping;Yang, Liusi;Zou, Mingchu;Zhang, Hui;Wu, Yizeng;Dai, Linxiu;Shang, Yuanyuan;Cao, Anyuan |
| 20-May-2020 |
Phase III study of tislelizumab plus chemotherapy vs chemotherapy alone as first-line (1L) treatment for advanced squamous non-small cell lung cancer (sq NSCLC). |
Wang, Jie;Yu, Xinmin;Lu, Shun;Hu, Yanping;Sun, Yuping;Wang, Zhijie;Zhao, Jun;Yu, Yan;Hu, Chunhong;Yang, Kunyu;Feng, Guosheng;Ying, Kejing;Zhuang, Wu;Zhou, Jianying;Wu, Jingxun;Wu, Yanjie;Lin, Xiao;Liang, Liang;Yang, Nong |
| Aug-2020 |
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA study |
Lu, Shun;Chen, Gongyan;Sun, Yuping;Sun, Sanyuan;Chang, Jianhua;Yao, Yu;Chen, Zhendong;Ye, Feng;Lu, Junguo;Shi, Jianhua;He, Jianxing;Liu, Xiaoqing;Zhang, Yiping;Liu, Zhihua;Fang, Jian;Cheng, Ying;Hu, Chunhong;Mao, Weidong;Hu, Yanping;Gong, Youling;Shan, Li;Yang, Zhixiong;Song, Yong;Li, Wei;Bai, Chong;Wang, Buhai;Ma, Rui;Zheng, Zhendong;Liu, Mingfang;Jie, Zhijun;Cao, Lejie;Liao, Wangjun;Pan, Hongming;Huang, Dongning;Chen, Yuan;Yang, Jinji;Qin, Shukui;Ma, Shenglin;Liang, Li;Liu, Zhe;Zhou, Jianying;Tao, Min;Huang, Yijiang;Qiu, Feng;Huang, Yunchao;Guan, Sha;Peng, Mengye;Su, Weiguo |
| Jun-2022 |
Research Status of and Trends in 3D Geological Property Modeling Methods: A Review |
Liu, Yuyang;Zhang, Xiaowei;Guo, Wei;Kang, Lixia;Gao, Jinliang;Yu, Rongze;Sun, Yuping;Pan, Mao |
| Jul-2021 |
A reservoir quality evaluation approach for tight sandstone reservoirs based on the gray correlation algorithm: A case study of the Chang 6 layer in the W area of the as oilfield, Ordos Basin |
Liu, Yuyang;Zhang, Xiaowei;Shi, Junfeng;Guo, Wei;Kang, Lixia;Yu, Rongze;Sun, Yuping;Wang, Zhelin;Pan, Mao |
| Feb-2022 |
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial |
Zhou, Caicun;Wang, Ziping;Sun, Yuping;Cao, Lejie;Ma, Zhiyong;Wu, Rong;Yu, Yan;Yao, Wenxiu;Chang, Jianhua;Chen, Jianhua;Zhuang, Wu;Cui, Jiuwei;Chen, Xueqin;Lu, You;Shen, Hong;Wang, Jingru;Li, Peiqi;Qin, Mengmeng;Lu, Dongmei;Yang, Jason |
| 2019 |
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial |
Jiang, Zefei;Li, Wei;Hu, Xichun;Zhang, Qingyuan;Sun, Tao;Cui, Shude;Wang, Shusen;Ouyang, Quchang;Yin, Yongmei;Geng, Cuizhi;Tong, Zhongsheng;Cheng, Ying;Pan, Yueyin;Sun, Yuping;Wang, Hong;Ouyang, Tao;Gu, Kangsheng;Feng, Jifeng;Wang, Xiaojia;Wang, Shubin;Liu, Tianshu;Gao, Jinghua;Cristofanilli, Massimo;Ning, Zhiqiang;Lu, Xianping |
| 19-Dec-2023 |
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma |
Duan, Jianchun;Zhang, Yun;Chen, Ran;Liang, Liang;Huo, Yi;Lu, Shun;Zhao, Jun;Hu, Chunhong;Sun, Yuping;Yang, Kunyu;Chen, Mingwei;Yu, Yan;Ying, Jianming;Huang, Ruiqi;Ma, Xiaopeng;Leaw, Shiangjiin;Bai, Fan;Shen, Zhirong;Cai, Shangli;Gao, Daming;Wang, Jie;Wang, Zhijie |
| 19-Dec-2023 |
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma |
Duan, Jianchun;Zhang, Yun;Chen, Ran;Liang, Liang;Huo, Yi;Lu, Shun;Zhao, Jun;Hu, Chunhong;Sun, Yuping;Yang, Kunyu;Chen, Mingwei;Yu, Yan;Ying, Jianming;Huang, Ruiqi;Ma, Xiaopeng;Leaw, Shiangjiin;Bai, Fan;Shen, Zhirong;Cai, Shangli;Gao, Daming;Wang, Jie;Wang, Zhijie |
